Edition:
United States

Conatus Pharmaceuticals Inc (CNAT.OQ)

CNAT.OQ on NASDAQ Stock Exchange Global Market

5.12USD
3:53pm EST
Change (% chg)

$-0.05 (-0.97%)
Prev Close
$5.17
Open
$5.16
Day's High
$5.22
Day's Low
$5.02
Volume
46,460
Avg. Vol
80,488
52-wk High
$9.40
52-wk Low
$3.88

Select another date:

Wed, Nov 1 2017

BRIEF-Conatus Pharmaceuticals reports Q3 revenue of $9.6 million

* Conatus Pharmaceuticals Inc reports third quarter 2017 financial results and program updates

BRIEF-EMA grants Conatus orphan drug designation for IDN-7314 for the treatment of PSC

* EMA grants Conatus orphan drug designation for IDN-7314 for the treatment of PSC

Select another date: